10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q3 2018

Filing Information

Form Type	10-Q
Accession Number	`0001651308-18-000003`
Period End Date	20180930
Filing Date	20181108
Fiscal Year	2018
Fiscal Period	Q3
XBRL Instance	bgne-20180930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 87 Income Statement 88 Cash Flow Statement 117 Comprehensive Income 28

Balance Sheet 87 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$208.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$239.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$643.49M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	592.07M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	771.06M	shares	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.56M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$1.39B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$597.91M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	592.07M	shares	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	771.06M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$37.37M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$29.43M	USD	Point-in-time
Unbilled receivable	`UnbilledReceivablesCurrent`	-	USD	Point-in-time
Unbilled receivable	`UnbilledReceivablesCurrent`	$4.88M	USD	Point-in-time
Inventories	`InventoryNet`	$19.70M	USD	Point-in-time
Inventories	`InventoryNet`	$10.93M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$35.62M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$69.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.18B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$913.50M	USD	Point-in-time
Restricted cash, non-current	`RestrictedCashAndCashEquivalentsNoncurrent`	$52.75M	USD	Point-in-time
Restricted cash, non-current	`RestrictedCashAndCashEquivalentsNoncurrent`	-	USD	Point-in-time
Restricted cash, non-current	`RestrictedCashAndCashEquivalentsNoncurrent`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$111.26M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$62.57M	USD	Point-in-time
Land use right, net	`LandUseRightNet`	$11.63M	USD	Point-in-time
Land use right, net	`LandUseRightNet`	$12.46M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$7.25M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$7.30M	USD	Point-in-time
Goodwill	`Goodwill`	$109.00K	USD	Point-in-time
Goodwill	`Goodwill`	$109.00K	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$7.67M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$16.47M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$42.91M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$28.91M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$228.43M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$132.98M	USD	Point-in-time
Total assets	`Assets`	$1.05B	USD	Point-in-time
Total assets	`Assets`	$2.41B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$85.55M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$69.78M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesAccountsPayableOtherAndOtherLiabilitiesCurrent`	$75.88M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesAccountsPayableOtherAndOtherLiabilitiesCurrent`	$49.60M	USD	Point-in-time
Deferred revenue, current	`ContractWithCustomerLiabilityCurrent`	$12.23M	USD	Point-in-time
Deferred revenue, current	`ContractWithCustomerLiabilityCurrent`	$16.70M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$9.16M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$1.55M	USD	Point-in-time
Current portion of long-term bank loan	`LongTermDebtCurrent`	$8.74M	USD	Point-in-time
Current portion of long-term bank loan	`LongTermDebtCurrent`	$9.22M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$149.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$188.42M	USD	Point-in-time
Long-term bank loan	`LongTermDebtNoncurrent`	$9.22M	USD	Point-in-time
Long-term bank loan	`LongTermDebtNoncurrent`	$40.82M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$146.41M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$146.27M	USD	Point-in-time
Deferred revenue, non-current	`ContractWithCustomerLiabilityNoncurrent`	$24.81M	USD	Point-in-time
Deferred revenue, non-current	`ContractWithCustomerLiabilityNoncurrent`	$14.66M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$31.96M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$34.88M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$212.26M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$236.77M	USD	Point-in-time
Total liabilities	`Liabilities`	$362.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$425.20M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 771,063,184 and 592,072,330 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	`CommonStockValue`	$59.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 771,063,184 and 592,072,330 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	`CommonStockValue`	$77.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.00B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.71B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-480.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-724.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-330.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-738.96M	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$1.97B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$669.81M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$14.42M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$12.98M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.98B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$1.05B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$2.41B	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$139.55M	USD	3 Qtrs
Revenues	`Revenues`	$220.21M	USD	1 Quarter
Revenues	`Revenues`	$54.20M	USD	1 Quarter
Revenues	`Revenues`	$220.21M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$19.51M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$1.94M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$1.94M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$8.71M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$177.68M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$87.66M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$421.54M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$147.59M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$122.89M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$48.82M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$35.19M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$15.64M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$63.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$63.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$188.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$563.00K	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$214.87M	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$205.30M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$105.31M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$564.51M	USD	3 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$-424.96M	USD	3 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$5.34M	USD	3 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$114.91M	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-151.10M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-1.78M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$4.55M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$8.00M	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-3.58M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$1.58M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$1.54M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$1.10M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$2.39M	USD	3 Qtrs
(Loss) income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$3.30M	USD	3 Qtrs
(Loss) income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-144.96M	USD	1 Quarter
(Loss) income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$114.22M	USD	1 Quarter
(Loss) income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-414.57M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-2.68M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-472.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-3.06M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-7.25M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$117.28M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.98M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-407.32M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-144.49M	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-237.00K	USD	3 Qtrs
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-102.00K	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-461.00K	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.81M	USD	3 Qtrs
Net (loss) income attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-144.03M	USD	1 Quarter
Net (loss) income attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-405.51M	USD	3 Qtrs
Net (loss) income attributable to BeiGene, Ltd.	`NetIncomeLoss`	$117.39M	USD	1 Quarter
Net (loss) income attributable to BeiGene, Ltd.	`NetIncomeLoss`	$6.22M	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.21	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.19	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.58	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.01	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.01	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.19	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.58	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.20	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	527.33M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	703.48M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	547.55M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	739.79M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	561.24M	shares	3 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	600.61M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	739.79M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	703.48M	shares	3 Qtrs
Basic (in dollars per share)	`EarningsperAmericanDepositoryShareBasic`	$-7.49	USD	3 Qtrs
Basic (in dollars per share)	`EarningsperAmericanDepositoryShareBasic`	$-2.53	USD	1 Quarter
Basic (in dollars per share)	`EarningsperAmericanDepositoryShareBasic`	$2.79	USD	1 Quarter
Basic (in dollars per share)	`EarningsperAmericanDepositoryShareBasic`	$0.15	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsperAmericanDepositoryShareDiluted`	$0.14	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsperAmericanDepositoryShareDiluted`	$-7.49	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsperAmericanDepositoryShareDiluted`	$-2.53	USD	1 Quarter
Diluted (in dollars per share)	`EarningsperAmericanDepositoryShareDiluted`	$2.54	USD	1 Quarter
Basic (in ADSs) (in shares)	`WeightedAverageNumberofAmericanDepositarySharesOutstandingBasic`	40.56M	shares	3 Qtrs
Basic (in ADSs) (in shares)	`WeightedAverageNumberofAmericanDepositarySharesOutstandingBasic`	56.91M	shares	1 Quarter
Basic (in ADSs) (in shares)	`WeightedAverageNumberofAmericanDepositarySharesOutstandingBasic`	54.11M	shares	3 Qtrs
Basic (in ADSs) (in shares)	`WeightedAverageNumberofAmericanDepositarySharesOutstandingBasic`	42.12M	shares	1 Quarter
Diluted (in ADSs) (in shares)	`WeightedAverageNumberofAmericanDepositarySharesOutstandingDiluted`	56.91M	shares	1 Quarter
Diluted (in ADSs) (in shares)	`WeightedAverageNumberofAmericanDepositarySharesOutstandingDiluted`	54.11M	shares	3 Qtrs
Diluted (in ADSs) (in shares)	`WeightedAverageNumberofAmericanDepositarySharesOutstandingDiluted`	46.20M	shares	1 Quarter
Diluted (in ADSs) (in shares)	`WeightedAverageNumberofAmericanDepositarySharesOutstandingDiluted`	43.17M	shares	3 Qtrs

Cash Flow Statement 117 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$117.28M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.98M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-407.32M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-144.49M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.70M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$7.03M	USD	3 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$26.40M	USD	3 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$61.17M	USD	3 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	-	USD	3 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$10.00M	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.00K	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-85.00K	USD	3 Qtrs
Non-cash interest expense	`InterestExpenseOperatingActivities`	$4.80M	USD	3 Qtrs
Non-cash interest expense	`InterestExpenseOperatingActivities`	$5.96M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-8.80M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-5.87M	USD	3 Qtrs
Disposal gain on available-for-sale securities	`MarketableSecuritiesRealizedGainLoss`	$10.00K	USD	3 Qtrs
Disposal gain on available-for-sale securities	`MarketableSecuritiesRealizedGainLoss`	$822.00K	USD	3 Qtrs
Non-cash amortization of bond discount	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Non-cash amortization of bond discount	`AmortizationOfDebtDiscountPremium`	$-4.44M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$10.52M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$7.94M	USD	3 Qtrs
Unbilled receivable	`IncreaseDecreaseInUnbilledReceivables`	$170.95M	USD	3 Qtrs
Unbilled receivable	`IncreaseDecreaseInUnbilledReceivables`	$-11.43M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$8.77M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$5.71M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$10.97M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$34.30M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$635.00K	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$8.50M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$21.42M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.58M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$26.28M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$22.37M	USD	3 Qtrs
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$1.12M	USD	3 Qtrs
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-7.61M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-5.68M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$38.61M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$180.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$12.91M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-353.82M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-81.00M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$27.44M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$47.03M	USD	3 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	-	USD	3 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$221.00K	USD	3 Qtrs
Prepayment of assets acquisition	`PrepaymentforAssetAcquisition`	-	USD	3 Qtrs
Prepayment of assets acquisition	`PrepaymentforAssetAcquisition`	$7.95M	USD	3 Qtrs
Payment for the acquisition of land use right	`PaymentsforLandUseRight`	$12.35M	USD	3 Qtrs
Payment for the acquisition of land use right	`PaymentsforLandUseRight`	-	USD	3 Qtrs
Cash acquired in business combination, net of cash paid	`CashAcquiredFromAcquisitionNetOfCashPaid`	$19.92M	USD	3 Qtrs
Cash acquired in business combination, net of cash paid	`CashAcquiredFromAcquisitionNetOfCashPaid`	-	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$514.13M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$2.12B	USD	3 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$245.93M	USD	3 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.33B	USD	3 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	-	USD	3 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$10.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-850.86M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-288.08M	USD	3 Qtrs
Proceeds from follow-on public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	$189.19M	USD	3 Qtrs
Proceeds from follow-on public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	$758.00M	USD	3 Qtrs
Payment of follow-on public offering cost	`PaymentsOfStockIssuanceCosts`	$674.00K	USD	3 Qtrs
Payment of follow-on public offering cost	`PaymentsOfStockIssuanceCosts`	$414.00K	USD	3 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	$149.93M	USD	3 Qtrs
Proceeds from HK IPO and global follow-on public offering	`ProceedsfromCommonStockIssuanceandInitialPublicOffering`	$875.37M	USD	3 Qtrs
Proceeds from HK IPO and global follow-on public offering	`ProceedsfromCommonStockIssuanceandInitialPublicOffering`	-	USD	3 Qtrs
Payment of HK IPO and global follow-on public offering costs	`PaymentsofInitialPublicOfferingCostandStockIssuanceCost`	$5.66M	USD	3 Qtrs
Payment of HK IPO and global follow-on public offering costs	`PaymentsofInitialPublicOfferingCostandStockIssuanceCost`	-	USD	3 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$42.31M	USD	3 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	-	USD	3 Qtrs
Repayment of long-term loan	`RepaymentsOfLongTermDebt`	$8.74M	USD	3 Qtrs
Repayment of long-term loan	`RepaymentsOfLongTermDebt`	-	USD	3 Qtrs
Proceeds from short-term loan	`ProceedsFromShortTermDebt`	$2.47M	USD	3 Qtrs
Proceeds from short-term loan	`ProceedsFromShortTermDebt`	-	USD	3 Qtrs
Repayment of short-term loan	`RepaymentsOfShortTermDebt`	-	USD	3 Qtrs
Repayment of short-term loan	`RepaymentsOfShortTermDebt`	$2.47M	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$14.53M	USD	3 Qtrs
Proceeds from shareholder loan	`ProceedsFromRelatedPartyDebt`	$132.76M	USD	3 Qtrs
Proceeds from shareholder loan	`ProceedsFromRelatedPartyDebt`	-	USD	3 Qtrs
Proceeds from option exercises	`ProceedsFromStockOptionsExercised`	$1.58M	USD	3 Qtrs
Proceeds from option exercises	`ProceedsFromStockOptionsExercised`	$20.86M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$487.31M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.68B	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.76M	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-5.86M	USD	3 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$471.19M	USD	3 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$121.00M	USD	3 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.51M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$208.51M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$239.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$710.80M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.51M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$208.51M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$239.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$710.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$208.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$239.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$643.49M	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.56M	USD	Point-in-time
Restricted cash, non-current	`RestrictedCashAndCashEquivalentsNoncurrent`	$52.75M	USD	Point-in-time
Restricted cash, non-current	`RestrictedCashAndCashEquivalentsNoncurrent`	-	USD	Point-in-time
Restricted cash, non-current	`RestrictedCashAndCashEquivalentsNoncurrent`	-	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$1.43M	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$12.15M	USD	3 Qtrs
Interest expense paid	`InterestPaidNet`	$1.55M	USD	3 Qtrs
Interest expense paid	`InterestPaidNet`	$940.00K	USD	3 Qtrs
Discount provided on sale of ordinary shares for business combination	`DiscountProvidedForIssuanceOfOrdinaryShares`	-	USD	3 Qtrs
Discount provided on sale of ordinary shares for business combination	`DiscountProvidedForIssuanceOfOrdinaryShares`	$23.61M	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$12.02M	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$1.48M	USD	3 Qtrs
Changes in operating assets and liabilities adjusted through accumulated deficit	`CumulativeEffectOnRetainedEarningsNetOfTax1`	-	USD	3 Qtrs
Changes in operating assets and liabilities adjusted through accumulated deficit	`CumulativeEffectOnRetainedEarningsNetOfTax1`	$-2.29M	USD	3 Qtrs

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Other comprehensive income, tax	`OtherComprehensiveIncomeLossTax`	-	USD	1 Quarter
Other comprehensive income, tax	`OtherComprehensiveIncomeLossTax`	-	USD	3 Qtrs
Other comprehensive income, tax	`OtherComprehensiveIncomeLossTax`	-	USD	3 Qtrs
Other comprehensive income, tax	`OtherComprehensiveIncomeLossTax`	-	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$117.28M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.98M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-407.32M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-144.49M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$985.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$341.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.22M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.91M	USD	3 Qtrs
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$58.00K	USD	3 Qtrs
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$354.00K	USD	1 Quarter
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.40M	USD	3 Qtrs
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$51.00K	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-148.35M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$117.68M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-407.83M	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.02M	USD	3 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-178.00K	USD	3 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-70.00K	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-486.00K	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.81M	USD	3 Qtrs
Comprehensive (loss) income attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$117.75M	USD	1 Quarter
Comprehensive (loss) income attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$7.20M	USD	3 Qtrs
Comprehensive (loss) income attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-147.87M	USD	1 Quarter
Comprehensive (loss) income attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-406.02M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.